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Background: The incidence of neonatal intraventricular hemorrhage (IVH) does not 
decrease even after using a surfactant and advanced intensive care. Posthemorrhagic 
hydrocephalus (PHH) is major complication after IVH. The roles of the ventricu-
loperitoneal (VP) shunt and the prognostic factors of neurodevelopmental outcomes 
in infants with PHH remain controversial. We compared the neurodevelopmental 
outcomes in newborns with and without VP shunts to delineate the clinical charac-
teristics of patients with PHH and to determine the useful prognostic factors of 
short-term outcomes and neurodevelopmental results at a corrected age of more 
than 1 year old.
Methods: We retrospectively reviewed the records of 83 cases of neonatal IVH, 
grades 2−4. Thirty (36%) of the cases were complicated with PHH. We classified sur-
vivors into four groups by outcome—normal, mildly abnormal, moderately abnormal, 
and severely abnormal—to compare prognoses.
Results: Among the 30 PHH cases, 10 patients died during their first admission (early 
deaths), and four died after their first discharge (late deaths). We found no statisti-
cally significant differences in gestational age, birth weight, gender, the maximum 
number of red blood cells in cerebral ventricular fluid, the lowest glucose levels, or 
total protein. Patients with grade 3 IVH were more likely to have shunts than were 
patients with grade 2 IVH. Patients with shunts had more late deaths and fewer 
normal neurodevelopmental outcomes than those without shunts.
Conclusion: Patients who were shunt-dependent had worse neurodevelopmental 
outcomes and greater mortality than those without shunts. The results appeared to 
depend on how far the hydrocephalus had progressed and on the degree of IVH, but 
the necessity of VP shunts requires reevaluation before they are implanted.
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1. Introduction
Even with advanced neonatal intensive care, intra-
ventricular hemorrhage (IVH) is a widely persistent 
problem in newborns. Posthemorrhagic hydroceph-
alus (PHH) is a major complication after IVH, which 
results in periventricular white matter damage due 
to compromised cerebral vascular flows, and the 
white matter injury can be exacerbated by PHH. 
Whether the hydrocephalus after IVH is due to the 
hemorrhage itself or is secondary to brain parenchy-
mal damage is sometimes difficult to distinguish. In-
fants who survive PHH have three main mechanisms 
contributing to poor subsequent neurodevelopmen-
tal outcomes. The first is a brain injury caused by the 
ventricular dilatation; the second, cerebral lesions 
secondary to various shunt- or ventricular-tapping-
related complications; and the third, the primary 
lesion caused by hemorrhagic and hypoxic ischemic 
factors.1 The management of PHH is inconsistent in 
different medical institutions. No definite proce-
dures have proved effective for preventing further 
ventriculoperitoneal (VP) shunting in newborns with 
PHH. Whether or not to implant permanent VP 
shunts is a difficult decision for clinicians because 
the benefits to the long-term neurodevelopmental 
outcome of an infant with PHH and a permanent 
shunt have not been definitely determined regard-
ing shunt-associated complications. In this retro-
spective study, we reviewed the literature about and 
investigated the clinical characteristics and neuro-
logical outcomes in infants with PHH, with and with-
out shunts.
2. Materials and Methods
We used brain sonography reports to retrospec-
tively collect records of premature infants born in 
our hospital between 1st January 2002, and 31st 
December 2007. We excluded cases with patients 
who had a congenital or chromosomal abnormality, 
meningitis, or diffuse cystic encephalomalacia. The 
IVH grade had been determined by a neonatologist 
or pediatric neurologist using standard criteria,2 as 
had been ventricular dilatation.3 Based on brain 
sonography, hydrocephalus was defined as progres-
sive ventricular dilatation. We defined rapidly pro-
gressive posthemorrhagic hydrocephalus (RPH) using 
three criteria: (1) a lumbar or ventricular tap showed 
an intracranial pressure ≥ 10 cmH2O; (2) the dis-
tance from the superior to the inferior border of 
the lateral ventricle just anterior to the trigone 
on a sagittal sonogram was > 1.5 cm and a brain 
sonogram showed severely increased ventricular size 
immediately after IVH; and (3) a growth per week 
in head circumference was > 2 cm.4 Cases were 
classified as slowly progressive posthemorrhagic 
hydrocephalus (SPH) if the patients did not meet 
the criteria of RPH.4 Brain sonography was done 
every day the first week, then every other day the 
second week until the patient was stable, or only 
once the second week if the first week’s findings 
had been negative. A lumbar tap was done first to 
remove cerebral spinal fluid (CSF) in patients with 
PHH, and then a ventricular tap if the lumbar tap 
had not worked.
The data collected for analysis were the maxi-
mum number of red blood cells (RBCs) in the CSF 
aspirated via the ventricular tap, and the mini-
mum glucose and maximum total protein levels in 
the CSF aspirated via the lumbar and ventricular 
taps. Patients who died before their first discharge 
from the hospital were classified as having an 
‘ear ly death’ and those who died after their first 
discharge were classified as having a ‘late death’. 
The neurological developmental outcomes were 
classified as normal, cerebral palsy (CP), and men-
tal retardation. CP was diagnosed using standard 
criteria.5 The functional impairments of cerebral 
palsy were divided into three categories: mild, the 
affected limbs were used nearly without limitation 
for daily activities; moderate, some use of the af-
fected limbs was retained; and severe, almost no 
use of the affected limbs was possible for daily 
activities.6 We evaluated these patients at the 
corrected ages of 6, 12, 18, and 24 months using 
Bailey’s test, which classified the neurodevelopmen-
tal quotient into ‘intelligence’ and ‘performance’. 
‘Normal’ was defined as both scores over 85, ‘mild’ 
as one of the two between 70 and 85, ‘moderate’ 
as both between 50 and 75, and ‘severe’ as both 
under 50. We divided the patients into four groups 
based on their neurodevelopmental outcomes: 
group 1 (normal), no neurological signs of CP and 
no delay of developmental milestones; group 2 
(mild), mild developmental delay or mild CP; group 
3 (moderate), moderate developmental delay or 
moderate CP; and group 4 (severe), severe devel-
opmental delay or severe CP. We divided patients 
with PHH into two groups, with and without shunts, 
and compared their clinical characteristics and 
outcomes.
2.1. Statistical analysis
The differences in the ratios and the distribution of 
the outcomes between groups were assessed using 
Fisher’s exact test. Values of p were all continuity-
corrected. The statistical differences between dif-
ferent groups were analyzed using an independent 
t-test (SPSS 14.0; SPSS Institute, Chicago, IL, USA). 
If the sample distribution was non-parametric, a 
Mann-Whitney U test would be chosen.
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3. Results
After excluding five patients with congenital anom-
alies, one with a chromosomal anomaly, seven with 
severe brain atrophy, and two who had suffered 
neonatal child abuse, we included 83 cases of pa-
tients with IVH (grades 2−4) (Figure 1). While only 
eight (13%) of the 61 grade 2 patients developed 
PHH, all 18 (100%) grade 3 and all four (100%) grade 
4 patients developed PHH. Among these 30, gesta-
tion age and birth weight ranged from 24 to 40 weeks 
(mean, 29 weeks; median, 28 weeks) and from 525 
to 2450 g (mean, 1233 g; median, 1055 g). The first 
postnatally detected IVH ranged from 1 to 8 days 
(mean, 4 days). The male:female ratio was 13:17. 
The mean duration of intubation was 20 days (range, 
0−375 days). Early death occurred in 10 (33%) PHH 
patients, seven with grade 3 IVH and three with 
grade 4. Late death after discharge occurred in four 
(13%) (Table 1).
We divided the 30 cases of PHH into two groups, 
early death and survivors, and found statistical dif-
ferences in gestational age, degree of IVH, Apgar 
score, and the progression of hydrocephalus, but not 
in birth weight, gender, or the severity of respiratory 
distress syndrome (RDS) (Table 2).
Of the 20 survivors, 12 (60%) had SPH and eight 
(40%) had RPH. Of the 12 SPH-group patients, six 
(50%) needed shunts, and six (50%) had a sponta-
neous remission of hydrocephalus. Among the eight 
RPH-group patients, six (75%) needed shunts and 
two (25%) did not. Three of eight patients (38%) with 
PHH and grade 2 IVH needed shunts, and the 
remaining five had a remission of hydrocephalus. 
Of 11 patients with PHH and grade 3 IVH, nine (82%) 
needed shunts and two did not. The shunt-
dependency ratio was statistically significantly (p = 
0.029) higher in grade 3 than in grade 2 (Table 2). 
IVH cases (n = 83)
Grade 2 (n = 61) Grade 3 (n = 18)
Survivor PHH (n = 20)
Excluded cases (n = 15)
Early death PHH* (n = 10)
Slowly progressive hydrocephalus (n = 12) Rapidly progressive hydrocephalus (n = 8)
Grade 4 (n = 4)
n = 7 n = 3
n = 1n = 8 n = 11
No shunts (n = 6)Shunts (n = 6) No shunts (n = 2)Shunts (n = 6)
Figure 1 Schematic representation of all IVH cases. IVH = intraventricular hemorrhage; PHH = posthemorrhagic 
hydrocephalus. *Early death was defined as a patient dying during the first admission.
Table 1  Clinical characteristics of 30 newborns with 
posthemorrhagic hydrocephalus (PHH)
Characteristics Values
Gestational age (wk) 29 ± 3.96; 28, 
(mean ± SD; median, range) 24−40
Birth body weight (g) 1233 ± 510; 1055,
(mean ± SD; median, range) 525−2450
Male:female 13:17
Multiple gestations 3
Grade of IVH
 2  8 (27%)
 3 18 (60%)
 4  4 (13%)
Duration of bleeding (d) 4.1 ± 1.7; 4, 1−8
(mean ± SD; median, range)
Apgar score 
(mean ± SD; median, range)
 1 minute 4.2 ± 2.2; 4, 0−9
 5 minutes 6.3 ± 1.8; 6.5, 3−10
Duration of intubation (d) 43 ± 69; 20, 0−375
(mean ± SD; median, range)
Early death before first 10 (33%)
discharge
Late death after first discharge  4 (13%)
IVH = intraventricular hemorrhage; SD = standard deviation.
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Of the 18 patients with grade 3 IVH, RPH-group 
patients had more early deaths than the SPH-group 
(63% vs. 20%; p = 0.04).
Neither gestational age nor birth weight nor gen-
der was significantly different between patients with 
and without shunts (Table 3). More RPH than SPH 
patients needed shunts (75% vs. 50%), but this differ-
ence was not statistically significant, nor were the 
number of lumbar and ventricular taps. The CSF max-
imum levels of RBCs from ventricular taps, low est 
levels of glucose, and highest levels of protein were 
also not statistically significantly different be tween 
the two groups. The only statistically signif icant dif-
ferences were the degrees of IVH, rate of late deaths, 
and normal developmental outcome at the corrected 
age of 1 year old. Grade 3 IVH patients were more 
likely to have a shunt than those with grade 2 (82% 
vs. 38%). More of the patients with VP shunts had a 
late death than those without shunts (40% vs. 0%), 
and there were fewer patients with a normal develop-
ment at the corrected age of 1 year old (0% vs. 50%) 
(Table 3). Ten (45%) of 22 patients with a VP shunt 
required revision; two shunts were infected and eight 
were malfunctioning, all less than 1 year af ter they 
had been inserted. Four of those 10 patients died 
and were part of the late death group.
4. Discussion
The present study appears to have answered the 
first question about the ventricular dilatation dam-
age to brain parenchyma. Most of our cases were 
grades 2−3 without parenchymal hemorrhage. The 
group with shunts had worse outcomes than the 
group without shunts. There are two possible expla-
nations for this. First, the group with shunts had more 
severe disease than the group without shunts. Sec-
ond, ventricular dilatation without brain damage 
does not obviously affect the final outcome of neu-
rodevelopment. Unnecessary VP shunts should be 
avoided because all the patients who died a late 
death died of shunt-related problems.
To increase the precision of the present study, we 
excluded cases in which the patients had chromo-
somal anomalies, congenital heart disease, neonatal 
child abuse, meningitis, or severe brain atrophy. Dif-
fuse cystic periventricular leukomalacia can also 
result in ventricular dilatation and be difficult to dis-
tinguish from pure PHH. Most important, however, it 
significantly affects neurodevelopmental outcomes. 
As mentioned above, one of the three brain damage 
mechanisms used by PHH is ventricular dilatation. 
The previous literature did not mention excluded 
cases and inevitably encountered a selection bias 
for neurodevelopmental outcomes.7,8
The birth rate in Taiwan has been decreasing in 
recent years, which has made it difficult to collect 
information about PHH cases. In the present study, 
case numbers were fewer also because of some eti-
ologies, including those of some of the cases we ex-
cluded. Statistical analysis, however, still provides 
a useful response to our initial question: Does 
ventricular dilatation cause brain injury?
According to the literature, between 35% and 
45% of premature neonates had IVH.4 Preventing IVH 
or periventricular hemorrhage (PVH) is critical but 
difficult. About 15% of infants develop PHH and 10% 
require shunts for severe and progressive PHH.4 In 
the present study, 14% of the PHH infants were shunt-
dependent, similar to other studies.4,7,8 However, 
the percentage of PHH in cases with IVH grades 2−3 
in the present study was about 36%, higher than in 
other studies.7,8 The difference may have been 
due to the definition of hydrocephalus used in the 
present study; in our cases, all had severe progres-
sive ventriculomegaly. Of those cases with grade 2 
IVH in our study, some patients developed severe 
PHH, some developed persistent but not progressive 
ventricular dilatation, and still others developed 
transient or no ventricular dilatation. A rat-model 
study of IVH9 reported initial ventricular dilatation 
peaking on day 2 after IVH and persisting for at 
least 8 weeks, which is similar to our finding. In the 
present study, 13% of the patients with grade 2 IVH 
Table 2  A comparison of the clinical characteristics 
between the early death and survivors 
groups of patients with posthemorrhagic 
hydrocephalus (PHH)
 Early death Survivors 
p value*
 (n = 10) (n = 20)
Gestational  26.9 ± 2.96 30.1 ± 4.02 0.02
age (wk)
Birth weight (g) 997.0 ± 423 1351.0 ± 518 ns
(mean ± SD)
Male:female 4:6 8:12 ns
Grade of IVH
 2 0  8 0.02
 3 7 11
 4 3  1
Apgar score
 1 minute 2.4 ± 1.7 5.0 ± 1.9 0.02
 5 minutes 5.2 ± 1.9 6.9 ± 1.6 0.02
RDS
 Normal 0  3 ns
 Mild 3  6
 Moderate 2  7
 Severe 4  4
Data are mean ± standard deviation (SD). *p values were 
mea sured using an independent t-test or Fisher’s exact 
test, when appropriate. IVH = intraventricular hemorrhage; 
RDS = respiratory distress syndrome; ns = not significant.
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progressed to PHH; others had persistent ventricu-
lomegaly but not progressive hydrocephalus; and 
patients with grades 3−4 IVH inevitably progressed 
to PHH. Another study also reported that 12% of 
grade 2 IVH patients progressed to PHH.8
Defining IVH is still difficult, although most doc-
tors have long been using the criteria described by 
Papile.2 Time is critical for grading. Sometimes it 
is difficult to distinguish between IVH grades 2 and 
3 and the difference between progressive and non-
progressive, and they often point to different out-
comes. Progressive ventriculomegaly means a more 
severe form of hydrocephalus, and non-progressive 
means a mild form of ventriculomegaly. Using sonog-
raphy only once, it is difficult to differentiate be-
tween PHH and transient ventriculomegaly after 
IVH or sub-acute chronic hydrocephalus.10 A series 
of follow-up brain sonograms is indicated. Other 
methods for grading IVH, such as neurological ex-
aminations and computerized tomography (CT) are 
unsuitable for preterm babies; therefore, brain 
sonography is a reliable and convenient tool for 
diagnosing IVH in premature infants.
Studies11−13 report different correlations between 
the volume of bleeding and VP shunts in newborns 
with PHH. In the present study, we found no signifi-
cant association between the maximum RBCs, ven-
tricular taps, lowest glucose, highest total protein, 
and the need for a shunt. We compared the two 
groups with maximum RBCs using a ventricular tap, 
which we believe represents the amount of bleeding 
within the ventricle. We often found that the max-
imum RBCs had peaked just after bleeding, and that 
the total protein was highest about 2−3 weeks after 
Table 3  Clinical characteristics of 20 newborns with posthemorrhagic hydrocephalus (PHH) with and without 
shunts
 With shunts Without shunts 
p value*
 (n = 12) (n = 8)
Gestational age (wk) 29.4 ± 3.7 31.1 ± 4.5 ns
Birth weight (g) 1453.0 ± 641 1420.0 ± 458 ns
Male:female 4:8 4:4 ns
Grade of IVH
 2 3 5 0.052**
 3 9 2
 4 0 1
RPH 6 (75%) 2 (25%) ns
SPH 6 (50%) 6 (75%) 
Time of first intervention (d) 14.0 ± 10.4 10.0 ± 5.1 ns
Number of lumbar taps 3.8 ± 3.2 4.1 ± 4.5 ns
Number of ventricular taps 9.5 ± 13.1 2.6 ± 2.8 ns
Maximum value of RBCs in CSF (number/μL) 18,173.0 ± 22,631 21,875.0 ± 43,211 ns
Lowest glucose value in CSF (mg/dL) 21.0 ± 17.7 31.5 ± 23.3 ns
(mean ± SD)
Highest protein value in 377.0 ± 287 310.0 ± 252 ns
CSF (mg/dL)
 With shunts Without shunts 
p value*Neurodevelopmental outcomes (corrected age > 1 yr)
 (n = 10***) (n = 8)
Late death after first discharge 4 (40%) 0 0.03
 Normal  0 (0%) 4 (50%) 0.008
 Mild 3 (30%) 3 (37%) ns
 Moderate 2 (20%) 0 ns
 Severe 1 (10%) 1 (13%) ns
Data are mean ± standard deviation (SD). *p value was measured using an independent t test or Fisher’s exact test, when appro-
priate. If sample distribution was nonparametric, a Mann-Whitney U test would be chosen. **p value was 0.052, cited due to the 
result demonstrating the trend of IVH grade and shunt implant. ***Two cases were < corrected aged 1 year. IVH = intraventricular 
hemorrhage; RBC = red blood cell; CSF = cerebral spinal fluid; RPH = rapidly progressive hydrocephalus; SPH = slowly progressive 
hydrocephalus; RDS = respiratory distress syndrome; ns = not significant.
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bleeding, and that then it went down. The majority 
of our cases showed hypoglycorrhachia in cerebral 
spinal fluid, and then a slow rise in CSF glucose. The 
hypoglycorrhachia was attributed to the consump-
tion of glucose by RBCs.
We found acute neurological deterioration in 
the early death cases. In one study,14 newborns with 
acute neurological deterioration had more severe 
neurological sequelae than did those without obvi-
ous neurological deterioration, a finding that agreed 
with the present study. One important predictor of 
early death is the degree of IVH. Seventy-five per-
cent of our patients with grade 4 and 33% with grade 
3 IVH had early deaths. In those cases with the same 
degree of IVH, we found that patients with RPH had 
a higher early mortality rate and worse neurodevel-
opmental outcomes than those with SPH. This finding 
was not mentioned in previous studies.4,7,8
The value of shunts in patients with PHH is still 
debated. In general, a series of lumbar and ven-
tricular taps may first be used to relieve increased 
intracranial pressure. Some patients with PHH will 
have a spontaneous remission after a series of lum-
bar or ventricular taps, but most patients with RPH 
will inevitably need VP shunts, as did 75% in the 
present study compared to 50% in the SPH group. 
It is difficult to decide the proper time to use a 
shunt; proper timing may prevent future shunt 
malfunctions, which usually contribute to second-
ary brain damage. We believe that the critical fac-
tors for determining the proper time are the levels 
of RBCs and total protein in CSF. It requires 2−3 
months after IVH to reduce the high RBC level and 
total protein in CSF.
For shunt-dependent patients, shunt infections 
and malfunctions are serious, life-threatening con-
ditions after they have been discharged from the 
hospital. In the present study, the shunt infections 
and malfunctions contributed substantially to pa-
tient mortality and morbidity, especially in the first 
postsurgical year. In one study,15 the shunt infec-
tion rate in premature infants with PHH was about 
22%, and 90% of the shunt infections occurred after 
the first shunt insertion. Shunt infections strongly 
correlated with the duration of follow-up and the 
number of shunt revisions.15 Early shunt infection is 
often due to intraoperative contamination, and late 
shunt infection is usually caused by other sources of 
contamination, such as hematogenous spreading, 
appendicitis, or bowel perforation.16 Being aware of 
these shunt problems is important because delayed 
revision can cause severe neurological sequelae, 
including death.
Shunts in patients with PHH usually make caregiv-
ers, including parents, anxious. There are several 
alternatives to shunts, including Ommaya reser-
voirs and third ventriculostomies. In one study17 of 
Ommaya reservoirs and third ventriculostomies in 
17 patients with PHH, 14 still developed PHH after 
Ommaya reservoir aspiration of 20 mL per tap, with 
an average of 11.4 times of aspiration. Ten of those 
14 patients were ultimately fitted with shunts. 
Ventriculoscopy is also a new and promising tech-
nique that allows the removal of some, but not all, 
permanent shunts, even after third ventriculosto-
mies.17 The role of endoscopic third ventriculosto-
mies to prevent shunt implants in the first months 
of life has not been studied; most studies focus on 
PHH with shunt implants in children 1 to 2 years 
old.18,19 A retrospective study19 reported an overall 
56% success rate for endoscopic third ventriculos-
tomies in children under 2 years old, and success in 
two of three children with PHH. This suggests that 
it is worthwhile considering an endoscopic ventricu-
lostomy an alternative method for a shunt-free life. 
One possible etiology of PHH is CSF absorption of 
arachnoid villi, which are damaged because of fi-
brosing arachnoiditis and meningeal fibrosis after 
IVH.20 This in turn results in third ventriculostomies 
and an inability to remove all shunts after PHH. If 
PHH is non-communicating hydrocephalus, the ob-
struction is in the sylvian aqueduct, in which case 
an endoscopic ventriculostomy is indicated.18 Our 
study showed that the third and fourth ventricles did 
not obviously dilate in most cases, which is compat-
ible with findings that infants with PHH will pro-
gress to obstructive hydrocephalus.18 In such cases, 
a third ventriculostomy may be a reasonable first 
alternative for precluding a permanent shunt and 
preventing neurological sequelae.
In conclusion, in the present study, newborns with 
PHH and VP shunts had worse neurodevelopmental 
outcomes than those without shunts. The severity of 
each patient’s hydrocephalus is important to the 
prognosis, but it seems warranted to reevaluate the 
necessity of implanting a VP shunt because most 
deaths of patients with a VP shunt can be attributed 
to shunt-associated consequences. Further prognostic 
factors of neurodevelopmental outcomes and search-
ing for an alternative method to remove permanent 
shunts are worth studying.
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